These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 23651024)

  • 1. Association of genetic variation in pharmacodynamic factors with methadone dose required for effective treatment of opioid addiction.
    Levran O; Peles E; Randesi M; Shu X; Ott J; Shen PH; Adelson M; Kreek MJ
    Pharmacogenomics; 2013 May; 14(7):755-68. PubMed ID: 23651024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic variants altering dopamine D2 receptor expression or function modulate the risk of opiate addiction and the dosage requirements of methadone substitution.
    Doehring A; Hentig Nv; Graff J; Salamat S; Schmidt M; Geisslinger G; Harder S; Lötsch J
    Pharmacogenet Genomics; 2009 Jun; 19(6):407-14. PubMed ID: 19373123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CYP2B6 SNPs are associated with methadone dose required for effective treatment of opioid addiction.
    Levran O; Peles E; Hamon S; Randesi M; Adelson M; Kreek MJ
    Addict Biol; 2013 Jul; 18(4):709-16. PubMed ID: 21790905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of OPRM1's genetic polymorphisms on methadone maintenance treatment in opioid addicts: a systematic review.
    Oueslati B; Moula O; Ghachem R
    Pharmacogenomics; 2018 Jun; 19(8):741-747. PubMed ID: 29785888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response to methadone maintenance treatment is associated with the MYOCD and GRM6 genes.
    Fonseca F; Gratacòs M; Escaramís G; De Cid R; Martín-Santos R; Fernández-Espejo E; Estivill X; Torrens M
    Mol Diagn Ther; 2010 Jun; 14(3):171-8. PubMed ID: 20560679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenomics of methadone: a narrative review of the literature.
    Packiasabapathy S; Aruldhas BW; Horn N; Overholser BR; Quinney SK; Renschler JS; Sadhasivam S
    Pharmacogenomics; 2020 Aug; 21(12):871-887. PubMed ID: 32705966
    [No Abstract]   [Full Text] [Related]  

  • 7. [Association between DRD2 gene polymorphisms and the dosage used on methadone maintenance treatment program].
    Duan LX; Li XL; Hu PW; Luo R; Luo X; Chen YY
    Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Feb; 39(2):194-198. PubMed ID: 29495204
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacogenetics of Methadone Response.
    Fonseca F; Torrens M
    Mol Diagn Ther; 2018 Feb; 22(1):57-78. PubMed ID: 29168075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic variants in NECTIN4 encoding an adhesion molecule are associated with continued opioid use.
    Fang CP; Liu TH; Chung RH; Tsou HH; Kuo HW; Wang SC; Liu CC; Liu SC; Chen ACH; Liu YL
    PLoS One; 2020; 15(6):e0234549. PubMed ID: 32555608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. OPRM1 and CYP3A4 association with methadone dose in Iranian patients undergoing methadone maintenance therapy.
    Akbari A; Kheradmand A; Sina M; Ahmadiani A; Asadi S
    J Addict Dis; 2021; 39(3):357-362. PubMed ID: 33682628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of BDNF and DRD2 genetic polymorphisms to continued opioid use in patients receiving methadone treatment for opioid use disorder: an observational study.
    Bawor M; Dennis BB; Tan C; Pare G; Varenbut M; Daiter J; Plater C; Worster A; Marsh DC; Steiner M; Anglin R; Desai D; Thabane L; Samaan Z
    Addict Sci Clin Pract; 2015 Oct; 10():19. PubMed ID: 26437921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of SNP-SNP interaction among ABCB1, ARRB2, DRD1 and OPRD1 on methadone dosage requirement in Han Chinese patients.
    Luo R; Li X; Qin S; Luo Z; Luo X; Hu P; Liu Z; Feng X; Li X
    Pharmacogenomics; 2017 Dec; 18(18):1659-1670. PubMed ID: 29173032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of genetic polymorphisms in ABCB1, CYP2B6, OPRM1, ANKK1 and DRD2 genes on methadone therapy in Han Chinese patients.
    Hung CC; Chiou MH; Huang BH; Hsieh YW; Hsieh TJ; Huang CL; Lane HY
    Pharmacogenomics; 2011 Nov; 12(11):1525-33. PubMed ID: 21902500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Add-On Selective Estrogen Receptor Modulators for Methadone Maintenance Treatment.
    Huang CL; Chiang YC; Chang WC; Su YT; Yang JC; Cheng WC; Lane HY; Ho IK; Ma WL
    Front Endocrinol (Lausanne); 2021; 12():638884. PubMed ID: 34434167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of OPRK1 gene polymorphisms with opioid dependence in addicted men undergoing methadone treatment in an Iranian population.
    Albonaim A; Fazel H; Sharafshah A; Omarmeli V; Rezaei S; Ajamian F; Keshavarz P
    J Addict Dis; 2017; 36(4):227-235. PubMed ID: 28786760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of
    Duan L; Li X; Yan J; Chen Y; Luo R; Zhang Q; Feng X; Li X
    Genet Test Mol Biomarkers; 2020 Jun; 24(6):364-369. PubMed ID: 32407152
    [No Abstract]   [Full Text] [Related]  

  • 17. Evidence-based treatment for opioid use disorders: A national study of methadone dose levels, 2011-2017.
    D'Aunno T; Park SE; Pollack HA
    J Subst Abuse Treat; 2019 Jan; 96():18-22. PubMed ID: 30466543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of the Brief Pain Inventory in Patients with Opioid Addiction Receiving Methadone Maintenance Treatment.
    Dennis BB; Roshanov PS; Bawor M; Paul J; Varenbut M; Daiter J; Plater C; Pare G; Marsh DC; Worster A; Desai D; Thabane L; Samaan Z
    Pain Physician; 2016 Jan; 19(1):E181-95. PubMed ID: 26752486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implications of OPRM1 and CYP2B6 variants on treatment outcomes in methadone-maintained patients in Ontario: Exploring sex differences.
    Chawar C; Hillmer A; Lamri A; Kapczinski F; Thabane L; Pare G; Samaan Z
    PLoS One; 2021; 16(12):e0261201. PubMed ID: 34910759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic polymorphisms in the opioid receptor mu1 gene are associated with changes in libido and insomnia in methadone maintenance patients.
    Wang SC; Tsou HH; Chen CH; Chen YT; Ho IK; Hsiao CF; Chou SY; Lin YF; Fang KC; Huang CL; Su LW; Fang YC; Liu ML; Wu HY; Lin KM; Liu SC; Kuo HW; Chiang IC; Chen AC; Tian JN; Liu YL
    Eur Neuropsychopharmacol; 2012 Oct; 22(10):695-703. PubMed ID: 22406240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.